MAC vs PECO
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The Macerich Company exhibits critical fundamental weakness, highlighted by a Piotroski F-Score of 2/9, indicating poor financial health. Despite a recent price rally, the company suffers from negative profit margins, shrinking year-over-year revenue (-17.40%), and a severe liquidity crunch with a current ratio of 0.45. The dividend is unsustainable with a payout ratio of 188.89%, and the forward P/E is deeply negative, suggesting significant earnings distress. The disconnect between the 'Buy' analyst consensus and the deterministic health scores suggests a high-risk speculative environment.
PECO exhibits a stable but mediocre Piotroski F-Score of 4/9, while trading at a significant premium to both its Graham Number ($19.08) and Intrinsic Value ($26.25). The most critical concern is the unsustainable dividend payout ratio of 140.81%, indicating the company is paying out more than it earns. Despite strong 5-year historical price performance and a 'Buy' analyst consensus, the combination of a bearish technical trend (10/100) and extreme valuation multiples suggests a high risk of correction.
Compare Another Pair
Related Comparisons
MAC vs PECO: Head-to-Head Comparison
This page compares The Macerich Company (MAC) and Phillips Edison & Company, Inc. (PECO) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.